- £101.35m
- £115.65m
- £1.05bn
- 82
- 92
- 59
- 93
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 671 | 688 | 676 | 879 | 1,054 |
Cost of Revenue | |||||
Gross Profit | 30.9 | 41.3 | 37.9 | 55.3 | 54.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 662 | 674 | 664 | 865 | 1,033 |
Operating Profit | 9.6 | 13.5 | 12.1 | 13.2 | 20.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 8.7 | 12 | 10.8 | 12 | 18.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 6.8 | 8.9 | 7.8 | 8.4 | 14.9 |
Net Income Before Extraordinary Items | |||||
Net Income | 6.8 | 8.9 | 7.8 | 8.4 | 14.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 6.8 | 8.9 | 7.8 | 8.4 | 14.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.146 | 0.185 | 0.166 | 0.288 | 0.301 |
Dividends per Share |